Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen.

Journal:
Diabetes Care
Published:
DOI:
10.2337/dc25-0690
Affiliations:
10
Authors:
8
Go to article
Institutions Authors Share
Tel Aviv Sourasky Medical Center, Israel
2.500000
 0.31
Tel Aviv University (TAU), Israel
1.833333
 0.23
Ariel University (AU), Israel
1.000000
 0.13
Leumit Health Services, Israel
1.000000
 0.13
Clalit Health Services, Israel
1.000000
 0.13
Gertner Institute for Epidemiology and Health Policy Research, Israel
0.333333
 0.04
Chaim Sheba Medical Center at Tel HaShomer, Israel
0.333333
 0.04
Interested in Clinical Sciences?